z-logo
Premium
Severe hyperprostaglandin E syndrome with hyperthyroidism — studies of pathogenetic mechanisms
Author(s) -
Fellman V.,
Pihko H.,
Majander A.,
Seyberth H. W.
Publication year - 1996
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/bf01799846
Subject(s) - polyuria , medicine , endocrinology , urinary system , metabolite , hypercalciuria , peroxisomal disorder , zellweger syndrome , adrenal disorder , peroxisome , diabetes mellitus , insulin resistance , receptor , glucose homeostasis
Summary Hyperprostaglandin E syndrome is a rare disease usually presenting with renal symptoms such as polyuria, polyhydramnios, hypercalciuria, hypokalaemia, and recurrent episodes of extreme fever, diarrhoea, and convulsions. We report a severe variant of this syndrome with obvious pain and prostaglandin E 2 (PGE 2 )‐stimulated hyperthyroidism, an association not previously described. Urinary excretion of PGE 2 and its metabolite 7 α ‐hydroxy‐5,11‐diketotetranorprosta‐1,16‐dioic acid were markedly increased above normal levels (to 53.3 and 1895 ng/h per 1.73 m 2 , respectively). We studied oxidative capacity of peroxisomes and mitochondria, the sites where PGE 2 oxidation takes place. A generalized mitochondrial disease could be ruled out and no deficiency was found in liver peroxisomal oxidases. The basic pathology of hyperprostaglandin E syndrome remains unsolved.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom